Sterling Capital Management’s Foghorn Therapeutics FHTX Stock Holding History

Sterling Capital Management’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.27K	Buy	1,196 +1,068	+834%	+$5.62K	﹤0.01%	2932
2026 Q2	$625	Sell	128 -360	-74%	-$1.6K	﹤0.01%	3203
2026 Q1	$2.33K	Sell	488 -359	-42%	-$1.97K	﹤0.01%	2964
2025 Q4	$4.57K	Buy	847 +92	+12%	+$417	﹤0.01%	2916
2025 Q3	$3.69K	Buy	755 +547	+263%	+$2.9K	﹤0.01%	2852
2025 Q2	$978	Buy	208 +20	+11%	+$84	﹤0.01%	3067
2025 Q1	$686	Sell	188 -166	-47%	-$757	﹤0.01%	2907
2024 Q4	$1.67K	Buy	354 +306	+638%	+$2.23K	﹤0.01%	2825
2024 Q3	$447	Buy	+48	New	+$348	﹤0.01%	2922

Other funds holding FHTX

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Sterling Capital Management's FHTX Position: Q3 2026 in Review

Sterling Capital Management increased its Foghorn Therapeutics (FHTX) stake by 834% in Q3 2026, buying an estimated $5.62K and bringing the position to 1,196 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Sterling Capital Management first reported a position in FHTX in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.57K in Q4 2025. 9 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

Sterling Capital Management held 1,196 shares of Foghorn Therapeutics worth $4.27K as of Q3 2026.
Sterling Capital Management bought 1,068 Foghorn Therapeutics shares in Q3 2026, an estimated $5.62K.
Foghorn Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2932 holding.
Sterling Capital Management first reported a position in Foghorn Therapeutics in Q3 2024 and has held it in 9 quarters since.
Sterling Capital Management's Foghorn Therapeutics position peaked at $4.57K in Q4 2025.
9 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.